Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flo… Read more
Bioventix (BVXP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.305x
Based on the latest financial reports, Bioventix (BVXP) has a cash flow conversion efficiency ratio of 0.305x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX3.52 Million) by net assets (GBX11.55 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioventix - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Bioventix's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioventix Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioventix ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wells Fargo & Company PFD DIV EQUALIZ
PINK:WFCNP
|
0.023x |
|
Valeo Pharma Inc
PINK:VPHIF
|
-0.007x |
|
DONGFENG MOTOR GP-H
MU:D4D
|
N/A |
|
Nam Mu Hydropower JSC
VN:HJS
|
N/A |
|
Rocca SA
WAR:RCA
|
-0.160x |
|
Entest Biomedical Inc
PINK:ETNI
|
0.337x |
|
ENGEN BOTSTWANA LIMITED
XBOT:ENG-EQO
|
N/A |
|
JIANGSU EXPRESS -H- (JE2.SG)
STU:JE2
|
N/A |
Annual Cash Flow Conversion Efficiency for Bioventix (2011–2025)
The table below shows the annual cash flow conversion efficiency of Bioventix from 2011 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | GBX11.55 Million | GBX7.03 Million | 0.609x | -12.44% |
| 2024-06-30 | GBX12.00 Million | GBX8.34 Million | 0.695x | +6.11% |
| 2023-06-30 | GBX12.06 Million | GBX7.90 Million | 0.655x | +2.42% |
| 2022-06-30 | GBX11.82 Million | GBX7.56 Million | 0.640x | +18.74% |
| 2021-06-30 | GBX11.82 Million | GBX6.37 Million | 0.539x | -12.67% |
| 2020-06-30 | GBX12.52 Million | GBX7.72 Million | 0.617x | +13.63% |
| 2019-06-30 | GBX10.83 Million | GBX5.88 Million | 0.543x | +0.94% |
| 2018-06-30 | GBX11.01 Million | GBX5.92 Million | 0.538x | +37.89% |
| 2017-06-30 | GBX10.14 Million | GBX3.96 Million | 0.390x | +0.93% |
| 2016-06-30 | GBX8.21 Million | GBX3.17 Million | 0.386x | +18.62% |
| 2015-06-30 | GBX6.58 Million | GBX2.15 Million | 0.326x | -3.36% |
| 2014-06-30 | GBX5.24 Million | GBX1.77 Million | 0.337x | +5.70% |
| 2013-06-30 | GBX4.20 Million | GBX1.34 Million | 0.319x | -14.04% |
| 2012-06-30 | GBX3.34 Million | GBX1.24 Million | 0.371x | +29.66% |
| 2011-06-30 | GBX2.68 Million | GBX766.14K | 0.286x | -- |